Molecular Templates is focused on the discovery, development, and commercialization of next-generation immunotoxins called Engineered Toxin Bodies (ETBs) for the treatment of cancers and other serious diseases.
Molecular Templates, Inc. Reports Third Quarter 2017 Financial Results Tue, 14 Nov 2017 21:01:00 +0000 Completed Merger with Threshold Pharmaceuticals in August. Recent Equity Financings of $60 Million Provide Cash Runway into late 2019. MT-3724 Advancing in Clinical Trials with New Data Expected in 1 H18....
Molecular Templates to Present at the 2017 BIO Investor Forum Fri, 06 Oct 2017 12:00:00 +0000 AUSTIN, Texas, Oct. 06, 2017-- Molecular Templates, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of Engineered Toxin Bodies, a new class of targeted biologic ...
5 of the Best Stocks Under $10 for 2017 Tue, 05 Sep 2017 16:41:04 +0000 Today we've highlighted five stocks that are currently trading for under $10 per share. These stocks are also showing signs for solid growth throughout 2017, and all of them currently hold a Zacks Rank #1 (Strong Buy).
Molecular Templates to Ring NASDAQ Closing Bell Friday, September 1, 2017 Wed, 30 Aug 2017 12:30:00 +0000 AUSTIN, Texas, Aug. 30, 2017-- Molecular Templates, Inc., a clinical stage biopharmaceutical company developing next generation immunotoxins called Engineered Toxin Bodies for the treatment of cancer, ...
*Winners defined as our Top Picks that increased 20% or more within a 6-month period.
Red Letters imply that that particular criteria did not meet minimum requirements, e.g., a low GSA Rank would show it in red.
___ Red Line On Graph Shows a Trailing Stop Loss Based on Support and Resistance Levels. See how it works.
___ Blue Line On Graph Shows the 10-Week Moving Average.
___ Magenta Line On Graph Shows the 40-Week Moving Average.
Disclaimer The stock selections in our stock investing and stock trading database are not stock recommendations, but simply represent applications of a stock investing process. All materials, including our Top Stock Picks, are provided for information purposes only and should not be used or construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security. Growth Stock Analytics, LLC is not responsible for gains/losses that may result in investing or trading in these securities. All information is believed to be obtained from reliable sources, but there is no guarantee that the information supplied is accurate, complete or timely. There is no guarantee or warranty with regard to the results obtained from its use. There is no guarantee of suitability or potential value of any particular investment or information source. You acknowledge that your requests for this information are unsolicited and shall neither constitute nor be considered investment advice. Past investing performance is not an indication of future performance results. Investing and trading in stocks is risky. Investors are encouraged to consult a registered stock broker or investment adviser before making any investing decisions. The interpretations and opinions expressed herein are solely those of Growth Stock Analytics, LLC, and not of any other individual or organization.